U.S. Structural Heart Imaging Market Size, Share & Trends Analysis Report By Modality (Echocardiogram, Angiogram), By Procedure (TAVR, SAVR, TMVR), By Application, By End-use, By Country,- Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2034

U.S. Structural Heart Imaging Market Size and Growth

The U.S. structural heart imaging market size was exhibited at USD 2.75 billion in 2024 and is projected to hit around USD 4.53 billion by 2034, growing at a CAGR of 5.11% during the forecast period 2025 to 2034.

U.S. Structural Heart Imaging Market Key Takeaways:

• The angiogram segment held the largest market share of about 36.4% in 2024.
• The CT segment is expected to grow at the fastest CAGR of 8% over the forecast period.
• Transcatheter Aortic Valve Replacement (TAVR) segment dominated the market by capturing a share of 23.4% in 2024.
• The Transcatheter Mitral Valve Repair (TMVR) segment is expected to grow significantly with a CAGR of 7.24% over the forecast period 2025 to 2034.
• The interventional cardiology segment dominated the market by capturing a share of more than 59.8% in 2024
• The diagnostic imaging segment is also expected to grow over the forecast period.
• Hospitals & clinics segment dominated the market with a share of nearly 55.0% in 2024.
• The ambulatory surgical centers segment is anticipated to experience the fastest growth of 6.80% over the forecast period.

Report Scope of U.S. Structural Heart Imaging Market

The rising prevalence of structural heart diseases, an aging population, and increasing adoption of minimally invasive procedures like TAVR and TMVR. Technological advancements such as 3D/4D echocardiography, AI-powered diagnostics, and fusion imaging have improved accuracy and efficiency in diagnosis and treatment planning. Expanding hospital infrastructure, increased awareness of early diagnosis, and collaborations between imaging companies and healthcare providers further fuel market growth.

The expansion of structural heart imaging in the U.S. is primarily driven by the growing prevalence of heart diseases and an increasing emphasis on preventive health checkups. Structural heart diseases, such as aortic stenosis, mitral regurgitation, and congenital heart defects, are becoming more common, particularly among the aging population, which is more vulnerable to these conditions. Early detection and accurate diagnosis are essential for managing these diseases effectively, fueling the demand for advanced imaging technologies. Simultaneously, patients are increasingly aware of the importance of preventive healthcare. People are increasingly opting for regular health screenings to detect potential cardiovascular issues before they become severe, which has led to a greater reliance on structural heart imaging solutions.

The presence of major manufacturers, such as Siemens Healthineers, GE Healthcare, and Koninklijke Philips N.V., is significantly driving market growth in the U.S. These industry leaders are consistently innovating and introducing advanced imaging products to meet the growing demand for accurate and efficient diagnostic solutions. For instance, in August 2024, Siemens Healthineers received FDA clearance for the ACUSON Origin, an advanced cardiovascular ultrasound system integrated with artificial intelligence (AI) capabilities. This advanced system is designed to enhance diagnostic accuracy and streamline workflows, demonstrating the industry's focus on leveraging AI to improve imaging outcomes. The continuous efforts of these key players to develop and commercialize new technologies not only cater to the rising prevalence of structural heart diseases but also strengthen the market's growth by offering healthcare providers state-of-the-art tools for patient care.

U.S. Structural Heart Imaging Market By Modality Insights

The angiogram segment held the largest market share of about 36.4% in 2024. This dominance can be attributed to its widespread use in diagnosing and evaluating structural heart diseases, such as coronary artery disease and congenital heart defects. Angiograms provide detailed imaging of blood vessels, enabling precise visualization of blockages, abnormalities, or structural issues, which are critical for treatment planning. In addition, advancements in imaging technologies, such as digital subtraction angiography (DSA) and 3D angiography, have further enhanced the accuracy and efficiency of these procedures, driving their adoption.

The CT segment is expected to grow at the fastest CAGR of 8% over the forecast period; this can be attributed to its increasing adoption in diagnosing and evaluating structural heart diseases. Computed tomography (CT) provides high-resolution, 3D images of the heart and surrounding structures, offering unparalleled accuracy in detecting anomalies such as valve defects, congenital abnormalities, and coronary artery disease. The integration of advanced technologies, such as dual-energy CT and AI-powered image processing, has further enhanced its diagnostic capabilities and efficiency. Moreover, the growing demand for non-invasive diagnostic methods and the expanding use of CT in pre-procedural planning for interventions like TAVR and TMVR contribute to this segment growth.

U.S. Structural Heart Imaging Market By Procedure Insights

Transcatheter Aortic Valve Replacement (TAVR) segment dominated the market by capturing a share of 23.4% in 2024. This dominance is owing to the growing preference for minimally invasive procedures to treat aortic stenosis, especially among high-risk and elderly patients who cannot undergo open-heart surgery. TAVR offers numerous benefits, including faster recovery times, lower procedural risks, and better patient outcomes, making it a suitable option for both patients and healthcare providers. Moreover, advancements in imaging technologies such as 3D echocardiography and CT have improved procedural planning and guidance, further boosting the adoption of TAVR. The rising prevalence of aortic stenosis and expanding FDA approvals have increased the segment's leading position in the structural heart imaging industry.

The Transcatheter Mitral Valve Repair (TMVR) segment is expected to grow significantly with a CAGR of 7.24% over the forecast period 2025 to 2034. This growth is driven by the increasing prevalence of mitral valve diseases, such as mitral regurgitation, particularly among the aging population. TMVR offers a minimally invasive alternative to open-heart surgery, making it an attractive option for high-risk patients or those ineligible for traditional surgical procedures. Advancements in imaging technologies, including 3D/4D echocardiography and fusion imaging, have enhanced procedural accuracy and outcomes, further encouraging the adoption of TMVR.

U.S. Structural Heart Imaging Market By Application Insights

The interventional cardiology segment dominated the market by capturing a share of more than 59.8% in 2024 and is also expected to grow at the fastest CAGR over the forecast period. This dominance is attributed to the increasing prevalence of cardiovascular diseases, including structural heart conditions, which require advanced interventional procedures for treatment. Furthermore, the adoption of minimally invasive techniques, such as Transcatheter Aortic Valve Replacement (TAVR) and Transcatheter Mitral Valve Repair (TMVR), depends on interventional cardiology devices and imaging technologies. Advancements in imaging systems, including 3D/4D echocardiography and intravascular ultrasound (IVUS), have significantly improved these procedures' precision and success rates, contributing to their growing popularity.

The diagnostic imaging segment is also expected to grow over the forecast period. This is owing to the increasing demand for accurate and non-invasive diagnostic tools for detecting and evaluating structural heart diseases. Advancements in imaging technologies, such as 3D/4D echocardiography, cardiac MRI, and CT, are enhancing diagnostic precision and procedural planning, driving adoption. Furthermore, the rising prevalence of cardiovascular conditions and the growing focus on early diagnosis and preventive healthcare are further contributing to the segment's expansion.

U.S. Structural Heart Imaging Market By End-use Insights

Hospitals & clinics segment dominated the market with a share of nearly 55.0% in 2024, driven by the availability of advanced diagnostic and imaging technologies, skilled healthcare professionals, and comprehensive patient care services. These facilities are primary points of care for diagnosing and treating structural heart diseases, offering access to advanced equipment and minimally invasive procedures such as TAVR and TMVR. Moreover, the growing prevalence of cardiovascular diseases and increasing patient visits for early diagnosis and treatment further contribute to the segment's growth.

The ambulatory surgical centers segment is anticipated to experience the fastest growth of 6.80% over the forecast period. This growth is driven by the increasing demand for cost-effective, efficient, and minimally invasive procedures performed in outpatient settings. ASCs offer shorter wait times, reduced hospital stays, and lower procedural costs compared to traditional hospital settings, making them an attractive option for patients and providers. In addition, advancements in portable imaging technologies and the growing preference for same-day procedures are fueling this segment's expansion.

Some of the prominent players in the U.S. structural heart imaging market include:

• Siemens Healthineers
• GE Healthcare
• Koninklijke Philips N.V.
• Canon Medical Systems
• Fujifilm Holdings Corporation
• Shanghai United Imaging Healthcare Co., LTD
• Abbott
• Terumo Corporation
• Samsung Medison Co., Ltd.
• Lepu Medical Technology

U.S. Structural Heart Imaging Market Recent Developments

• In July 2024, GE Healthcare announced its agreement to acquire Intelligent Ultrasound Group PLC’s (Intelligent Ultrasound) clinical artificial intelligence (AI) software business for a total consideration of approximately USD 51 million.
  
  
• In January 2024, Siemens Healthineers expanded its partnership with City Cancer Challenge (C/Can) on a global scale, aiming to provide support for C/Can city projects in low- and middle-income countries.
  
  
• In October 2024, Shanghai United Imaging Healthcare Co., LTD announced a strategic partnership with INVIA, a leading provider of medical imaging software, at the European Association of Nuclear Medicine (EANM) 2024 Congress. This collaboration aims to improve nuclear cardiology solutions by fully integrating INVIA’s Corridor4DM into United Imaging’s AI-powered advanced visualization workspace, uOmnispace.
  
  
• In January 2024, Siemens Healthineers announced FDA clearance for the MAGNETOM Cima.X, a 3 Tesla (3T) whole-body magnetic resonance imaging (MRI) scanner. Featuring the most powerful gradient system ever in a clinically approved whole-body MRI scanner, it enables visualization of smaller anatomical structures and captures images more quickly than its predecessors.

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the U.S. structural heart imaging market

By Modality

• Echocardiogram
• Angiogram
• CT
• MRI
• Nuclear Imaging
• Other Modalities

By Procedure

• Transcatheter Aortic Valve Replacement (TAVR)
• Surgical Aortic Valve Replacement (SAVR)
• Transcatheter Mitral Valve Repair (TMVR)
• Left Atrial Appendage Closure (LAAC)
• Tricuspid Valve Replacement and Repair
• Paravalvular Leak Detection and Repair
• Annuloplasty
• Valvuloplasty
• Other Structural Heart Procedures

By Application

• Diagnostic Imaging
• Interventional Cardiology

By End-use

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Diagnostic Imaging Centers
• Other End Use